Filing Details
- Accession Number:
- 0001209191-23-059693
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-26 17:24:30
- Reporting Period:
- 2023-12-21
- Accepted Time:
- 2023-12-26 17:24:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1556263 | Syros Pharmaceuticals Inc. | SYRS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1253170 | Srinivas Akkaraju | C/O Syros Pharmaceuticals, Inc. 35 Cambridge Park Drive Cambridge MA 02140 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-12-21 | 904,977 | $4.42 | 1,786,427 | No | 4 | P | Indirect | By Samsara BioCapital, L.P. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Samsara BioCapital, L.P. |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,666 | Direct |
Footnotes
- Shares are held by Samsara BioCapital L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. The Reporting Person has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein.
Billionaire Hedge Funds
